Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antitumor drug for intermittent administration of FGFR inhibitor

Antitumor drug for intermittent administration of FGFR inhibitor

US Patent 10894048 · Granted Jan 19, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antitumor agent and method for tumor therapy2024
Method for reducing content of saturated hydrocarbon, and refined palm-based oil2023
Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a me2015
Dihydropyrazolopyrimidinone derivatives2014
Combination cancer therapy with an AKT inhibitor and other anticancer agents2013
Substrate, semiconductor device using the same, method for inspecting semiconduc2011
Dihydropyrazolopyrimidinone derivatives2011
Substituted pyrazolo[3,4-d]pyrimidinone derivatives2010
Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton2010
Quinoxalinone derivatives2008
Cyclin D binding factor, and uses thereof2004
Cyclin D binding factor, and uses thereof2001